领航医药生物科技(00399)发布公告,经参考公司审核委员会的推荐建议,其已议决建议委任永拓富信会计师事务所有限公司为公司新任核数师,并担任公司核数师直至公司下届股东周年大会结束为止,但须待公司股东于公司将举行的股东特别大会上批准后,方可作实。
责任编辑:卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.